All these data allowed the authors to conclude that in cancer cells, the complex PHF5A–SF3b binds the H3K4me3-containing promoters and then is recruited by the transcriptional machinery facilitating the AS of FASTK to yield the inactive variant. Here, FASTK is linked to cancer.